Activity improvement of antimicrobial peptides by a chemical modification approach: Toward the creation of novel types of antimicrobial agents

Mini-Reviews in Organic Chemistry

Volumn 7, Issue 4, 2010, Pages 282-289

  Hashimoto, Shigeki ^a   Taguchi, Seiichi ^b  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Activity spectrum; Amino acid; Antimicrobial activity; Cell membrane; Disulfide bond; Peptide

Indexed keywords

ANTIBIOTICS; ANTIMICROBIAL AGENTS; CHEMICAL MODIFICATION; COVALENT BONDS; CYTOLOGY; MICROORGANISMS; PEPTIDES; POLYPEPTIDES; SULFUR COMPOUNDS;

ACTIVITY SPECTRUM; AMINO-ACIDS; ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL PEPTIDE; BACTERIAL STRAINS; DISULPHIDE BONDS; HIGH SELECTIVITY; PROPERTY; RESISTANCE PROBLEMS; SPECTRA'S;

AMINO ACIDS;

EID: 77958181824     PISSN: 1570193X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157019310792246373     Document Type: Article

References (79)

1. Epand, R. M.; Vogel, H. J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1999, 1462, 11.
2. Shai, Y.; Oren, Z. From carpet mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 2001, 22, 1629.
3. Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415, 389.
4. Powers, J. P.; Hancock, R. E. The relationship between peptide structure and antibacterial activity. Peptides 2003, 24, 1681.
5. Brogden, K. A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 2005, 3, 238.
6. Toke, O. Antimicrobial peptides: new candidates in the fight against bacterial infections. Biopolymers 2005, 80, 717.
7. Zasloff, M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA 1987, 84, 5449.
8. Christensen, B.; Fink, J.; Merrifield, R. B.; Mauzerall, D. Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc. Natl. Acad. Sci. USA 1988, 85, 5072.
9. Matsuzaki, K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta, 1998, 1376, 391.
10. Ganz, T.; Lehrer, R. I. Defensins. Curr. Opin. Immunol. 1994, 6, 584.
11. Mangoni, M. E.; Aumelas, A.; Charnet, P.; Roumestand, C.; Chiche, L.; Despaux, E.; Grassy, G.; Calas, B.; Chavanieu, A. Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formation. FEBS Lett. 1996, 383, 93.
12. Cociancich, S.; Ghazi, A.; Hetru, C.; Hoffmann, J. A.; Letellier, L. Insect defensin, an inducible antibacterial peptide, forms voltage-dependent channels in Micrococcus luteus. J. Biol. Chem. 1993, 268, 19239.
13. Selsted, M. E.; Novotny, M. J.; Morris, W. L.; Tang, Y. Q.; Smith, W.; Cullor, J. S. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J. Biol. Chem. 1992, 267, 4292.
14. Castle, M.; Nazarian, A.; Yi, S. S.; Tempst, P. Lethal effects of apidaecin on Escherichia coli involve sequential molecular interactions with diverse targets. J. Biol. Chem. 1999, 274, 32555.
15. Hancock, R. E.; Falla, T.; Brown, M. Cationic bactericidal peptides. Adv. Microb. Physiol. 1995, 37, 135.
16. Fehlbaum, P.; Bulet, P.; Chernysh, S.; Briand, J. P.; Roussel, J. P.; Letellier, L.; Hetru, C.; Hoffmann, J. A. Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc. Natl. Acad. Sci. USA 1996, 93, 1221.
17. Chen, H. C.; Brown, J. H.; Morell, J. L.; Huang, C. M. Synthetic magainin analogues with improved antimicrobial activity. FEBS Lett. 1988, 236, 462.
18. Fimland, G.; Eijsink, V. G.; Nissen-Meyer, J. Mutational analysis of the role of tryptophan residues in an antimicrobial peptide. Biochemistry 2002, 41, 9508.
19. Chen, Y.; Mant, C. T.; Farmer, S. W.; Hancock, R. E.; Vasil, M. L.; Hodges, R. S. Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 2005, 280, 12316.
20. Strom, M. B.; Rekdal, O.; Svendsen, J. S. Antibacterial activity of 15-residue lactoferricin derivatives. J. Pept. Res. 2000, 56, 265.
21. Wu, M.; Hancock, R. E. Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide. Antimicrob. Agents Chemother. 1999, 43, 1274.
22. Lee, K. H.; Lee, D. G.; Park, Y.; Kang, D. I.; Shin, S. Y.; Hahm, K. S.; Kim, Y. Interactions between the plasma membrane and the antimicrobial peptide HP (2-20) and its analogues derived from Helicobacter pylori. Biochem. J. 2006, 394, 105.
23. Andra, J.; Monreal, D.; Martinez de Tejada, G.; Olak, C.; Brezesinski, G.; Gomez, S. S.; Goldmann, T.; Bartels, R.; Brandenburg, K.; Moriyon, I. Rationale for the design of shortened derivatives of the NK-lysin-derived antimicrobial peptide NK-2 with improved activity against Gram-negative pathogens. J. Biol. Chem. 2007, 282, 14719.
24. Park, Y.; Park, S. C.; Park, H. K.; Shin, S. Y.; Kim, Y.; Hahm, K. S. Structure-activity relationship of HP (2-20) analog peptide: enhanced antimicrobial activity by N-terminal random coil region deletion. Biopolymers 2007, 88, 199.
25. Schmidtchen, A.; Pasupuleti, M.; Morgelin, M.; Davoudi, M.; Alenfall, J.; Chalupka, A.; Malmsten, M. Boosting antimicrobial peptides by hydrophobic oligopeptide end tags. J. Biol. Chem. 2009, 284, 17584.
26. Taguchi, S.; Mita, K.; Ichinohe, K.; Hashimoto, S. Targeted engineering of the antibacterial peptide apidaecin, based on an in vivo monitoring assay system. Appl. Environ. Microbiol. 2009, 75, 1460.
27. Taguchi, S.; Nakagawa, K.; Maeno, M.; Momose, H. In vivo monitoring system for structure-function relationship analysis of the antibacterial peptide apidaecin. Appl. Environ. Microbiol. 1994, 60, 3566.
28. Taguchi, S.; Ozaki, A.; Nakagawa, K.; Momose, H. Functional mapping of amino acid residues responsible for the antibacterial action of apidaecin. Appl. Environ. Microbiol. 1996, 62, 4652.
29. Matsumoto, K.; Orikasa, Y.; Ichinohe, K.; Hashimoto, S.; Ooi, T.; Taguchi, S. Flow cytometric analysis of the contributing factors for antimicrobial activity enhancement of cell-penetrating type peptides: case study on engineered apidaecins. Biochem. Biophys. Res. Commun. 2010, 395, 7.
30. Epand, R. M. Biophysical studies of lipopeptide-membrane interactions. Biopolymers 1997, 43, 15.
31. Avrahami, D.; Shai, Y. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action. Biochemistry 2003, 42, 14946.
32. Thennarasu, S.; Lee, D. K.; Tan, A.; Prasad Kari, U.; Ramamoorthy, A. Antimicrobial activity and membrane selective interactions of a synthetic lipopeptide MSI-843. Biochim. Biophys. Acta 2005, 1711, 49.
33. Straus, S. K.; Hancock, R. E. Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: comparison with cationic antimicrobial peptides and lipopeptides. Biochim. Biophys. Acta 2006, 1758, 1215.
34. Chu-Kung, A. F.; Bozzelli, K. N.; Lockwood, N. A.; Haseman, J. R.; Mayo, K. H.; Tirrell, M. V. Promotion of peptide antimicrobial activity by fatty acid conjugation. Bioconjug. Chem. 2004, 15, 530.
35. Lockwood, N. A.; Haseman, J. R.; Tirrell, M. V.; Mayo, K. H. Acylation of SC4 dodecapeptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains. Biochem. J. 2004, 378, 93.
36. Wakabayashi, H.; Matsumoto, H.; Hashimoto, K.; Teraguchi, S.; Takase, M.; Hayasawa, H. N-Acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity. Antimicrob. Agents Chemother. 1999, 43, 1267.
37. Majerle, A.; Kidric, J.; Jerala, R. Enhancement of antibacterial and lipopolysaccharide binding activities of a human lactoferrin peptide fragment by the addition of acyl chain. J. Antimicrob. Chemother. 2003, 51, 1159.
38. Mak, P.; Pohl, J.; Dubin, A.; Reed, M. S.; Bowers, S. E.; Fallon, M. T.; Shafer, W. M. The increased bactericidal activity of a fatty acid-modified synthetic antimicrobial peptide of human cathepsin G correlates with its enhanced capacity to interact with model membranes. Int. J. Antimicrob. Agents 2003, 21, 13.
39. Radzishevsky, I. S.; Rotem, S.; Zaknoon, F.; Gaidukov, L.; Dagan, A.; Mor, A. Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. Antimicrob. Agents Chemother. 2005, 49, 2412.
40. Rydlo, T.; Rotem, S.; Mor, A. Antibacterial properties of dermaseptin S4 derivatives under extreme incubation conditions. Antimicrob. Agents Chemother. 2006, 50, 490.
41. Shalev, D. E.; Rotem, S.; Fish, A.; Mor, A. Consequences of N-acylation on structure and membrane binding properties of dermaseptin derivative K4-S4-(1-13). J. Biol. Chem. 2006, 281, 9432.
42. Chou, H. T.; Kuo, T. Y.; Chiang, J. C.; Pei, M. J.; Yang, W. T.; Yu, H. C.; Lin, S. B.; Chen, W. J. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp. Int. J. Antimicrob. Agents 2008, 32, 130.
43. Zelezetsky, I.; Tossi, A. Alpha-helical antimicrobial peptides-using a sequence template to guide structure-activity relationship studies. Biochim. Biophys. Acta 2006, 1758, 1436.
44. Oh, J. E.; Lee, K. H. Synthesis of novel unnatural amino acid as a building block and its incorporation into an antimicrobial peptide. Bioorg. Med. Chem. 1999, 7, 2985.
45. Xie, J.; Schultz, P. G. A chemical toolkit for proteins-an expanded genetic code. Nat. Rev. Mol. Cell. Biol. 2006, 7, 775.
46. Oh, D.; Shin, S. Y.; Lee, S.; Kang, J. H.; Kim, S. D.; Ryu, P. D.; Hahm, K. S.; Kim, Y. Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures. Biochemistry 2000, 39, 11855.
47. Falla, T. J.; Hancock, R. E. Improved activity of a synthetic indolicidin analog. Antimicrob. Agents Chemother. 1997, 41, 771.
48. Friedrich, C. L.; Moyles, D.; Beveridge, T. J.; Hancock, R. E. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 2000, 44, 2086.
49. Friedrich, C. L.; Rozek, A.; Patrzykat, A.; Hancock, R. E. Structure and mechanism of action of an indolicidin peptide derivative with improved activity against gram-positive bacteria. J. Biol. Chem. 2001, 276, 24015.
50. Strom, M. B.; Rekdal, O.; Stensen, W.; Svendsen, J. S. Increased antibacterial activity of 15-residue murine lactoferricin derivatives. J. Pept. Res. 2001, 57, 127.
51. Sitaram, N.; Sai, K. P.; Singh, S.; Sankaran, K.; Nagaraj, R. Structure-function relationship studies on the frog skin antimicrobial peptide tigerinin 1: design of analogs with improved activity and their action on clinical bacterial isolates. Antimicrob. Agents Chemother. 2002, 46, 2279.
52. Jing, W.; Hunter, H. N.; Hagel, J.; Vogel, H. J. The structure of the antimicrobial peptide Ac-RRWWRF-NH2 bound to micelles and its interactions with phospholipid bilayers. J. Pept. Res. 2003, 61, 219.
53. Wei, S. Y.; Wu, J. M.; Kuo, Y. Y.; Chen, H. L.; Yip, B. S.; Tzeng, S. R.; Cheng, J. W. Solution structure of a novel tryptophan-rich peptide with bidirectional antimicrobial activity. J. Bacteriol. 2006, 188, 328.
54. Haug, B. E.; Svendsen, J. S. The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide. J. Pept. Sci. 2001, 7, 190.
55. Haug, B. E.; Skar, M. L.; Svendsen, J. S. Bulky aromatic amino acids increase the antibacterial activity of 15-residue bovine lactoferricin derivatives. J. Pept. Sci. 2001, 7, 425.
56. Haug, B. E.; Stensen, W.; Stiberg, T.; Svendsen, J. S. Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides. J. Med. Chem. 2004, 47, 4159.
57. Savoia, D.; Guerrini, R.; Marzola, E.; Salvadori, S. Synthesis and antimicrobial activity of dermaseptin S1 analogues. Bioorg. Med. Chem. 2008, 16, 8205.
58. Mor, A.; Hani, K.; Nicolas, P. The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. J. Biol. Chem. 1994, 269, 31635.
59. Yoder, N. C.; Kumar, K. Fluorinated amino acids in protein design and engineering. Chem. Soc. Rev. 2002, 31, 335.
60. Bilgicer, B.; Kumar, K. De novo design of defined helical bundles in membrane environments. Proc. Natl. Acad. Sci. USA 2004, 101, 15324.
61. Lee, K. H.; Lee, H. Y.; Slutsky, M. M.; Anderson, J. T.; Marsh, E. N. Fluorous effect in proteins: de novo design and characterization of a four-alpha-helix bundle protein containing hexafluoroleucine. Biochemistry 2004, 43, 16277.
62. Lee, H. Y.; Lee, K. H.; Al-Hashimi, H. M.; Marsh, E. N. Modulating protein structure with fluorous amino acids: increased stability and native-like structure conferred on a 4-helix bundle protein by hexafluoroleucine. J. Am. Chem. Soc. 2006, 128, 337.
63. Gottler, L. M.; de la Salud Bea, R.; Shelburne, C. E.; Ramamoorthy, A.; Marsh, E. N. Using fluorous amino acids to probe the effects of changing hydrophobicity on the physical and biological properties of the beta-hairpin antimicrobial peptide protegrin-1. Biochemistry 2008, 47, 9243.
64. Gimenez, D.; Andreu, C.; del Olmo, M.; Varea, T.; Diaz, D.; Asensio, G. The introduction of fluorine atoms or trifluoromethyl groups in short cationic peptides enhances their antimicrobial activity. Bioorg. Med. Chem. 2006, 14, 6971.
65. Gottler, L. M.; Lee, H. Y.; Shelburne, C. E.; Ramamoorthy, A.; Marsh, E. N. Using fluorous amino acids to modulate the biological activity of an antimicrobial peptide. Chembiochem 2008, 9, 370.
66. Meng, H.; Kumar, K. Antimicrobial activity and protease stability of peptides containing fluorinated amino acids. J. Am. Chem. Soc. 2007, 129, 15615.
67. Wu, Z.; Hoover, D. M.; Yang, D.; Boulegue, C.; Santamaria, F.; Oppenheim, J. J.; Lubkowski, J.; Lu, W. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc. Natl. Acad. Sci. USA 2003, 100, 8880.
68. Kluver, E.; Schulz-Maronde, S.; Scheid, S.; Meyer, B.; Forssmann, W. G.; Adermann, K. Structure-activity relation of human beta-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity. Biochemistry 2005, 44, 9804.
69. Rao, A. G. Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds. Arch. Biochem. Biophys. 1999, 361, 127.
70. Derksen, D. J.; Stymiest, J. L.; Vederas, J. C. Antimicrobial leucocin analogues with a disulfide bridge replaced by a carbocycle or by noncovalent interactions of allyl glycine residues. J. Am. Chem. Soc. 2006, 128, 14252.
71. Derksen, D. J.; Boudreau, M. A.; Vederas, J. C. Hydrophobic interactions as substitutes for a conserved disulfide linkage in the type IIa bacteriocins, leucocin A and pediocin PA-1. Chembiochem 2008, 9, 1898.
72. Yan, L. Z.; Gibbs, A. C.; Stiles, M. E.; Wishart, D. S.; Vederas, J. C. Analogues of bacteriocins: antimicrobial specificity and interactions of leucocin A with its enantiomer, carnobacteriocin B2, and truncated derivatives. J. Med. Chem. 2000, 43, 4579.
73. Dalet, K.; Cenatiempo, Y.; Cossart, P.; Hechard, Y. A sigma(54)-dependent PTS permease of the mannose family is responsible for sensitivity of Listeria monocytogenes to mesentericin Y105. Microbiology 2001, 147, 3263.
74. Ramnath, M.; Arous, S.; Gravesen, A.; Hastings, J. W.; Hechard, Y. Expression of mptC of Listeria monocytogenes induces sensitivity to class IIa bacteriocins in Lactococcus lactis. Microbiology 2004, 150, 2663.
75. Imamura, T.; Yamamoto, N.; Tamura, A.; Murabayashi, S.; Hashimoto, S.; Shimada, H.; Taguchi, S. NMR based structure-activity relationship analysis of an antimicrobial peptide, thanatin, engineered by site-specific chemical modification: Activity improvement and spectrum alteration. Biochem. Biophys. Res. Commun. 2008, 369, 609.
76. Mandard, N.; Sodano, P.; Labbe, H.; Bonmatin, J. M.; Bulet, P.; Hetru, C.; Ptak, M.; Vovelle, F. Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data. Eur. J. Biochem. 1998, 256, 404.
77. Taguchi, S.; Kuwasako, K.; Suenaga, A.; Okada, M.; Momose, H. Functional mapping against Escherichia coli for the broad-spectrum antimicrobial peptide, thanatin, based on an in vivo monitoring assay system. J. Biochem. 2000, 128, 745.
78. Lee, M. K.; Cha, L.; Lee, S. H.; Hahm, K. S. Role of amino acid residues within the disulfide loop of thanatin, a potent antibiotic peptide. J. Biochem. Mol. Biol. 2002, 35, 291.
79. Orikasa, Y.; Ichinohe, K.; Saito, J.; Hashimoto, S.; Matsumoto, K.; Ooi, T.; Taguchi, S. The hydrophobicity in a chemically modified side-chain of cysteine residues of thanatin is related to antimicrobial activity against Micrococcus luteus. Biosci. Biotechnol. Biochem. 2009, 73, 1683.